Asthma: Pathology and pathophysiology

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 4, 2006, Pages 447-451

  Barrios, Roberto J ^a   Kheradmand, Farrah ^b   Batts, LaKeisha ^b   Corry, David B ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; IMMUNOGLOBULIN RECEPTOR;

ASTHMA; BRONCHUS MUCOSA; CHEST TIGHTNESS; CHRONIC INFLAMMATION; COUGHING; DISEASE ASSOCIATION; DYSPNEA; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; PATHOPHYSIOLOGY; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; REVIEW; SMOOTH MUSCLE; UNITED STATES; WHEEZING; BRONCHUS; IMMUNOLOGY; PATHOLOGY;

ASTHMA; BRONCHI; HUMANS; RECEPTORS, IMMUNOLOGIC;

EID: 33645775249     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Epstein MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol. 2004;133:84-100.
2. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999;17:255-281.
3. Corry DB, Grunig G, Hadeiba H, et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med. 1998;4:344-355.
4. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258-2261.
5. Obiri NI, Debinski W, Leonard WJ, Puri RK. Receptor for interleukin 13: interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem. 1995;270:8797-8804.
6. Lefort S, Vita N, Reeb R, Caput D, Ferrara P. IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. FEBS Lett. 1995;366:122-126.
7. Smerz-Bertling C, Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem. 1995;270:966-970.
8. Murata T, Puri RK. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells. Cell Immunol. 1997;175:33-40.
9. Orchansky PL, Ayres SD, Hilton DJ, Schrader JW. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J Biol Chem. 1997;272:22940-22947.
10. Palmer-Crocker RL, Hughes CC, Pober JS. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest. 1996;98:604-609.
11. Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol. 1991;147:1387-1391.
12. Finkelman FD, Katona IM, Urban JF Jr, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol. 1988;141:2335-2341.
13. Snapper CM, Finkelman FD, Paul WE. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med. 1988;167:183-196.
14. Finkelman FD, Katona IM, Urban JF Jr, Paul WE. Control of in vivo IgE production in the mouse by interleukin 4. Ciba Found Symp. 1989;147:3-22.
15. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989;245:308-310.
16. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27-33.
17. Dunnill MS. The pathology of asthma. Ciba Found Study Group. 1971;38:35-46.
18. Messer JW, Peters GA, Bennett WA. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest. 1960;38:616-624.
19. Boulet LP, Laviolette M, Turcotte H, et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest. 1997;112:45-52.
20. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033-1039.
21. Cho SH, Seo JY, Choi DC, et al. Pathological changes according to the severity of asthma. Clin Exp Allergy. 1996;26:1210-1219.
22. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990;142:434-457.
23. Grootendorst DC, Sont JK, Willems LN, et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy. 1997;27:769-779.
24. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 1989;140:1745-1753.
25. Laitinen LA, Laitinen A, Altraja A, et al. Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol. 1996;98(5, pt 2):S3-6; discussion S33-40.
26. Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998;157:403-409.
27. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156(3, pt 1):737-743.
28. Ordonez CL, Khashayar R, Wong HH, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 2001;163:517-523.
29. Calhoun WJ, Sedgwick J, Busse WW. The role of eosinophils in the pathophysiology of asthma. Ann N Y Acad Sci. 1991;629:62-72.
30. Holgate ST, Lackie PM, Davies DE, Roche WR, Walls AF. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy. 1999;29(suppl 2):90-95.
31. Jeffery PK, Laitinen A, Venge P. Biopsy markers of airway inflammation and remodelling. Respir Med. 2000;94(suppl F):S9-15.
32. Salvato G. Some histological changes in chronic bronchitis and asthma. Thorax. 1968;23:168-172.
33. Jeffery PK. Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150(5, pt 2): S6-13.
34. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992;101:916-921.
35. Jelihovsky T. The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma. Histopathology. 1983;7:153-167.
36. Minshall EM, Leung DV, Martin RJ, et al. Eosinophil-assodated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1997;17:326-333.
37. Thurlbeck W, Wright JL. Thurlbeck's Chronic Airway Obstruction. 2nd ed. Hamilton, Ontario: BC Decker; 1999.
38. Bhaskar KR, O'Sullivan DD, Coles SJ, Kozakewich H, Vawter GP, Reid LM. Characterization of airway mucus from a fatal case of status asthmaticus. Pediatr Pulmonol. 1988;5:176-182.
39. Reid L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax. 1960;15:132-141.
40. Reid L, Jones R. Bronchial mucosal cells. Fed Proc. 1979;38:191-196.
41. Rjabucha NA. [Morphometric picture of chronic bronchitis in bronchiectases: morphologic and morphometric changes in the proximal and distal bronchi and bronchioles.] Z Erkr Atmungsorgane. 1987;168:9-18.
42. Carroll N, Lehmann E, Barret J, Morton A, Cooke C, James A. Variability of airway structure and inflammation in normal subjects and in cases of nonfatal and fatal asthma. Pathol Res Pract. 1996;192:238-248.
43. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993;148:1220-1225.
44. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis. 1991;143:138-143.
45. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993;147:405-410.
46. Bai TR, Cooper J, Koelmeyer T, Pare PD, Weir TD. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med. 2000;162(2, pt 1):663-669.
47. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1990;3:507-511.
48. Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1997;156(2, pt 1):591-599.
49. Redington AE, Madden J, Frew AJ, et al. Transforming growth factor-beta 1 in asthma: measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997;156(2, pt 1):642-647.
50. Djukanovic R, Wilson JW, Lai CK, Holgate ST, Howarth PH. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis. 1991;143(4, pt 1):772-777.
51. Humbert M, Robinson DS, Assoufi B, Kay AB, Durham SR. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax. 1996;51:664-669.
52. ten Hacken NH, Aleva RM, Oosterhoff Y, et al. Submucosa 1.0 × 0.1 mm in size is sufficient to count inflammatory cell numbers in human airway biopsy specimens. Mod Pathol. 1998;11:292-294.